|
|
 |
 |
|
|
|
|
Allergan in $600 million Botox settlement
|
02-Sep-2010
|
Allergan has agreed to pay $375 million to settle criminal charges and $225 million to resolve civil claims as part of a settlement with the US Department of Justice over the company’s US sales and marketing practices related to Botox (onabotulinumtoxinA), which the government maintains the firm was promoting for a number of unapproved uses.
Read more...
|
|
Novartis wins FDA nod for blood pressure pill
|
27-Aug-2010
|
Novartis has won US Food and Drug Administration approval for a high blood pressure therapy called Tekamlo, which is a single-pill combination of the company’s renin inhibitor Tekturna (aliskiren) and the calcium channel blocker amlodipine, which is the active ingredient in Pfizer’s top-selling high blood pressure medication Norvasc
Read more...
|
|
J&J’s DePuy recalls devices
|
27-Aug-2010
|
Johnson & Johnson’s DePuy Orthopaedics unit is recalling two kinds of hip implants that appear to be linked to the need for a higher number of second procedures known as revision surgeries
Read more...
|
|
US News in Brief, August 26, 2010
|
26-Aug-2010
|
Cephalon CEO on leave
Stem cell ruling will be appealed
P&G to co-promote sleep drug
EpiCept Ceplene NDA rejected
Pfizer lung cancer study disappoints
FDA advisors back expanded Cymbalta use
Jazz drug nixed by FDA advisors
Read more...
|
|
Bill would increase FDA recall powers
|
06-Aug-2010
|
New legislation has been introduced in the Senate that would give the US Food and Drug Administration the authority to force companies to recall drugs in cases in which the products have been found to be contaminated or unsafe
Read more...
|
|
US News in Brief, August 6, 2010
|
06-Aug-2010
|
Study suggests bias in industry research
FDA lifts hold on stem-cell trial
New flu shots approved
GSK forms two new drug partnerships
New recommendations on FDA device reviews
Read more...
|
|
US News in Brief, July 30, 2010
|
30-Jul-2010
|
FDA clears Daiichi hypertension drug
Merck Serono MS pill wins priority review
Astellas and Regeneron extend deal
Counterfeit medicines summit
FDA approves drug for drooling
Read more...
|
|
First generic Lovenox approved
|
29-Jul-2010
|
In a controversial move, the US Food and Drug Administration has approved for marketing the first generic version of sanofi-aventis’ blockbuster blood-thinner Lovenox (enoxaparin sodium injection), which is indicated for a number of uses, including prevention of deep vein thrombosis
Read more...
|
|
|
Page 1 2 
|
 |
|
|
|
|
